Serial Number
88764198
Owner
Passage Bio, Inc.Attorney
Connie L. EllerbachFirst Use Date
Mar 29, 2021
Filing Date
Jan 17, 2020
PASSAGE BIO Trademark
Serial Number: 88764198 • Registration: 7145870
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
January 17, 2020
Registration Date
August 22, 2023
First Use Anywhere
March 29, 2021
First Use in Commerce
March 29, 2021
Published for Opposition
May 19, 2020
Goods & Services
Pharmaceutical research and development; clinical research in the field of genetic medicine, gene therapy and regenerative medicines; testing, inspection, research, or development of pharmaceutical preparations and substances for genetic medicine, gene therapy and regenerative medicines; biological information analysis, namely, genetic testing for medical research purposes; scientific research in the fields of medicine, genetics, genetic medicines, regenerative medicines, gene therapy, biologics, and central nervous system diseases; providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; medical and scientific research, namely, conducting clinical trials for others; compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease
Pharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies; pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system; medicines for human purposes, namely, for treating genetically based diseases and disorders; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy for rare monogenic central nervous system diseases; pharmaceutical compositions containing adeno-associated virus (AAV) vectors for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders